5-甲氧基-2-硝基苯甲酸甲酯 | 2327-45-9

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-甲氧基-2-硝基苯甲酸甲酯
• 中文别名: 2-硝基-5-甲氧基苯甲酸甲酯
• 英文名称: methyl 5-methoxy-2-nitrobenzoate
• 英文别名: 2-Nitro-5-methoxy-benzoesaeure-methylester
• CAS: 2327-45-9
• 化学式: C₉H₉NO₅
• mdl: MFCD00662902
• 分子量: 211.174
• InChiKey: UAPJKEJWOPOJJY-UHFFFAOYSA-N

物化性质

• 熔点：
  58-59 °C
• 沸点：
  196-198 °C(Press: 15-16 Torr)
• 密度：
  1.294±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  81.4
• 氢给体数：
  0
• 氢受体数：
  5

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2918990090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 5-methoxy-2-nitrobenzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 5-methoxy-2-nitrobenzoate
CAS number: 2327-45-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9NO5
Molecular weight: 211.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-甲氧基-2-硝基苯甲酸甲酯 在 sodium tetrahydroborate 、 sodium hydroxide 、 水 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 3.0h， 以78%的产率得到(5-甲氧基-2-硝基苯基)甲醇
  参考文献：
  名称：

  [EN] SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS
  [FR] DERIVES TRIAZOLE SUBSTITUES UTILISES EN TANT QU'ANTAGONISTES DE L'OXYTOCINE

  摘要：

  这项发明涉及具有氧催产素拮抗活性的化合物(I)，其用途，其制备方法以及含有该抑制剂的组合物。这些抑制剂在多种治疗领域中具有用途，包括性功能障碍，特别是早泄（P.E.）。

  公开号：

  WO2005121152A1
• 作为产物：
  描述：

  5-甲氧基-2-硝基苯甲酸 在 氯化亚砜 作用下， 以 甲醇 为溶剂， 反应 20.0h， 以83%的产率得到5-甲氧基-2-硝基苯甲酸甲酯
  参考文献：
  名称：

  [EN] BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS
  [FR] COMPOSÉS BICYCLIQUES SUBSTITUÉS PAR HÉTÉROARYLE

  摘要：

  公开了公式(I)至(VIII)的化合物：(I) (II) (III) (IV) (V) (VI) (VII) (VIII)；或其立体异构体、互变异构体、药物可接受的盐、溶剂化物或前药，其中R3是与0至3个R3a取代的双环杂芳基团；且R1、R2、R3a、R4和n在此定义。还公开了使用这些化合物作为PAR4抑制剂的方法，以及包含这些化合物的药物组合物。这些化合物用于抑制或预防血小板聚集，用于治疗血栓栓塞障碍或作为血栓栓塞障碍的初级预防。

  公开号：

  WO2018013774A1

文献信息

• Relative reactivity of methyl iodide to ethyl iodide in nucleophilic substitution reactions in acetonitrile and partial desolvation accompanying activation
  作者：Yasuhiko Kondo、Miyuki Urade、Yukari Yamanishi、Xinyu Chen

  DOI：10.1039/b203032m

  日期：——

  have been deduced on the basis of these classifications. A major factor determining the relative reactivity of methyl iodide to ethyl iodide in the substitution reaction of an anionic nucleophile having a single reaction site in acetonitrile (kMeI/kEtI) is suggested to be partial desolvation around the nucleophilic center on going from reactant to transition-state.

  通过检验涉及的经验相关性 激活 亲核取代的参数 甲基碘 和的 碘乙烷亲核试剂已经被分为三个系列：（1）具有两个等效反应位点的亲核试剂，（2）在对位具有氯原子的亲核试剂，和（3）具有单个反应位点的亲核试剂。伴随的三种类型的部分去溶剂化过程激活根据这些分类推论得出。决定相对活性的主要因素甲基碘 到 碘乙烷 在一个具有单个反应位点的阴离子亲核试剂的取代反应中 乙腈（k MeI / k EtI）建议是从反应物到过渡态时亲核中心周围的部分去溶剂化。
• AROMATIC SULFONE COMPOUND AS ALDOSTERONE RECEPTOR MODULATOR
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP1844768A1

  公开（公告）日：2007-10-17

  The present invention provides a compound represented by the following formula (I): [wherein, A represents a group of the following formula (A-1): etc., R1 and R2 each independently represent a hydrogen atom etc., Z represents CR3 etc., W represents CR4 etc., Q represents CR5 etc., R3, R4 and R5 each independently represent a hydrogen atom etc., Y represents an oxygen atom or sulfur atom, X represents an oxygen atom etc. and B represents an optionally substituted aryl group or optionally substituted heteroaryl group], the prodrug thereof or the pharmaceutically acceptable salt thereof for preventing or treating various diseases such as hypertesion, cerebral stroke, cardiac failure, etc.

  本发明提供了以下式（I）所表示的化合物： [其中，A表示以下式（A-1）的基团： 等等，R1和R2分别独立表示氢原子等，Z表示CR3等，W表示CR4等，Q表示CR5等，R3、R4和R5分别独立表示氢原子等，Y表示氧原子或硫原子，X表示氧原子等，B表示可选择地取代的芳基或可选择地取代的杂环基]，其前药或其药学上可接受的盐，用于预防或治疗高血压、脑卒中、心力衰竭等各种疾病。
• Copper-Catalyzed Methyl Esterification Reactions via C–C Bond Cleavage
  作者：Yan Zhu、Hong Yan、Linhua Lu、Defu Liu、Guangwei Rong、Jincheng Mao

  DOI：10.1021/jo4016387

  日期：2013.10.4

  The highly effective synthesis of methyl esters from benzylic alcohols, aldehydes, or acids via copper-catalyzed C–C cleavage from tert-butyl hydroperoxide is reported in this paper for the first time. Our protocol is easily accessible and practical, making it a possible supplement for the traditional way.

  本文首次报道了通过铜催化的氢过氧化叔丁基的铜催化CC裂解，由苄醇，醛或酸高效合成甲酯。我们的协议易于访问且实用，使其成为传统方式的可能补充。
• Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
  作者：Carlotta Granchi、Giulia Bononi、Rebecca Ferrisi、Eleonora Gori、Giulia Mantini、Sandra Glasmacher、Giulio Poli、Stefano Palazzolo、Isabella Caligiuri、Flavio Rizzolio、Vincenzo Canzonieri、Tiziana Perin、Jürg Gertsch、Andrea Sodi、Elisa Giovannetti、Marco Macchia、Filippo Minutolo、Tiziano Tuccinardi、Andrea Chicca

  DOI：10.1016/j.ejmech.2020.112857

  日期：2021.1

  endocannabinoid system is monoacylglycerol lipase (MAGL). This enzyme, which metabolizes the endocannabinoid 2-arachidonoylglycerol (2-AG), has attracted great interest due to its involvement in several physiological and pathological processes, such as cancer progression. Experimental evidences highlighted some drawbacks associated with the use of irreversible MAGL inhibitors in vivo, therefore the research field

  内源性大麻素系统的一种有趣酶是单酰基甘油脂肪酶（MAGL）。该酶可代谢内源性大麻素2-花生四烯酰基甘油（2-AG），由于它参与了一些生理和病理过程，例如癌症进展，因此引起了极大的兴趣。实验证据突显了与体内不可逆MAGL抑制剂的使用相关的一些缺点因此，关于可逆抑制剂的研究领域正在迅速发展。在本手稿中，基于苯甲酰基哌啶的MAGL抑制剂的种类进一步扩大和优化。酶促测定法鉴定出了一些在低纳摩尔范围内的化合物，分子动力学模拟预测了最好的化合物之一与酶的解离路线，从而证实了所观察到的构效关系。生物学评估，包括在完整的U937细胞中进行测定以及在小鼠脑膜中进行基于竞争活性的蛋白质谱分析实验，证实了所选化合物对MAGL与内源性大麻素系统其他成分的选择性。在一组癌细胞系中的抗增殖能力凸显了它们作为潜在抗癌药的潜力。
• Efficient synthesis of NIR emitting bis[2-(2′-hydroxylphenyl)benzoxazole] derivative and its potential for imaging applications
  作者：Junfeng Wang、Hannah Baumann、Xiaoman Bi、Leah P. Shriver、Zhaoda Zhang、Yi Pang

  DOI：10.1016/j.bioorg.2020.103585

  日期：2020.3

  Unassymetric bis[2-(2'-hydroxyphenylbenzoxole)] bis(HBO) derivatives with a DPA functionality for zinc binding have been developed with an efficient synthetic route, using the retrosynthetic analysis. Comparison of bis(HBO) derivatives with different substitution patterns allows us to verify and optimize their unique fluorescence properties. Upon binding zinc cation, bis(HBO) derivatives give a large

  使用逆合成分析，已经开发出具有有效的合成途径的具有DPA官能团的锌的不对称双[2-（2'-羟基苯基苯并恶唑）]双（HBO）衍生物。比较具有不同取代模式的bis（HBO）衍生物，可以验证和优化其独特的荧光性质。结合锌阳离子后，bis（HBO）衍生物在可见光（λem≈536 nm）和近红外（NIR）窗口（λem≈746 nm）中都提供大的荧光开启。探针很容易被488 nm激光激发，这使得该系列化合物成为在共聚焦显微镜上进行体外和体内研究的合适成像工具。在细胞环境和血栓成像中已成功证明了锌结合诱导的荧光开启的应用。